Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBiswas, Sinjini-
dc.contributor.authorDuffy, Stephen J-
dc.contributor.authorLefkovits, Jeffrey-
dc.contributor.authorAndrianopoulos, Nick-
dc.contributor.authorBrennan, Angela-
dc.contributor.authorWalton, Antony-
dc.contributor.authorChan, William-
dc.contributor.authorNoaman, Samer-
dc.contributor.authorShaw, James A-
dc.contributor.authorDawson, Luke-
dc.contributor.authorAjani, Andrew-
dc.contributor.authorClark, David J-
dc.contributor.authorFreeman, Melanie-
dc.contributor.authorHiew, Chin-
dc.contributor.authorOqueli, Ernesto-
dc.contributor.authorReid, Christopher M-
dc.contributor.authorStub, Dion-
dc.identifier.citationThe American Journal of Cardiology 2018; 121(3): 279-288en_US
dc.description.abstractOver the last decade, systems of care for ST-elevation myocardial infarction (STEMI) have evolved to try to improve outcomes and timely access to percutaneous coronary intervention (PCI). There have also been advances in PCI techniques and adjunctive pharmacotherapies. In this study, we sought to determine temporal changes in practices and clinical outcomes of PCI in patients with STEMI. We prospectively collected data on 8,412 consecutive patients undergoing PCI for STEMI between 2005 and 2016 in the multicenter Melbourne Interventional Group registry. Data were divided by procedure year for trends analysis. The primary end point was 30-day mortality. Patient demographics and comorbidities including smoking and diabetes have remained stable. The volume of primary PCI performed within 12 hours of symptom onset has significantly risen (65.7% to 80.1%, p < 0.01). The proportion of patients achieving the recommended door-to-balloon time ≤90 minutes has also risen (37.6% to 59.0%, p < 0.01). Patient complexity has also increased with more patients after out of-hospital cardiac arrest with STEMI now being treated with PCI (2.6% to 9.1%, p < 0.01). A shift from mainly femoral to radial access and from bare-metal to drug-eluting stent use was seen. Glycoprotein IIb/IIIa inhibitors are being used less frequently with increasing use of newer antiplatelet agents. Thirty-day mortality has remained low throughout the study period at 6.5% overall. In conclusion, although timely access to primary PCI has improved, mortality rates have remained unchanged, but remain low and compare favorably with international data. Australian PCI practice has overall evolved in response to evidence and emergence of new adjunctive device and pharmacotherapies.en_US
dc.titleAustralian Trends in Procedural Characteristics and Outcomes in Patients Undergoing Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleThe American Journal of Cardiologyen_US
dc.identifier.affiliationDepartment of Cardiovascular Medicine, The Alfred Hospital, Melbourne, Australiaen_US
dc.identifier.affiliationDepartment of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australiaen_US
dc.identifier.affiliationDepartment of Cardiology, Ballarat Health Services, Ballarat, Australiaen_US
dc.identifier.affiliationSchool of Public Health, Curtin University, Perth, Australiaen_US
dc.identifier.affiliationDepartment of Cardiology, Royal Melbourne Hospital, Melbourne, Australiaen_US
dc.identifier.affiliationBaker IDI Heart and Diabetes Institute, Melbourne, Australiaen_US
dc.identifier.affiliationDepartment of Cardiology, Box Hill Hospital, Melbourne, Australiaen_US
dc.identifier.affiliationDepartment of Cardiology, University Hospital Geelong, Geelong, Australiaen_US
dc.type.austinJournal Article-, David J
item.fulltextNo Fulltext-
item.openairetypeJournal Article-
item.languageiso639-1en- of Melbourne Clinical School-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

checked on Jun 14, 2024

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.